A Retrospective, Multi-center Study of Rabbit Anti-thymocyte Immunoglobulin (Thymoglobuline) Induction Therapy in Kidney Transplant Recipients Using Organs Donated After Cardiac Death in China
Latest Information Update: 08 Nov 2019
Price :
$35 *
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- Sponsors Sanofi China Investment
- 28 Oct 2019 Status changed from recruiting to completed.
- 24 Jan 2018 Status changed from not yet recruiting to recruiting.
- 27 Apr 2017 New trial record